Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Journal of Geriatric Oncology|February 22, 2016
A review and assessment of currently available data of the EGFR antibodies in elderly patients with metastatic colorectal cancerGerardo Rosati, Giuseppe Aprile, Giovanni Gerardo Cardellino, et al.
Anticancer Research|August 21, 2003
Raltitrexed and mitomycin-C as third-line chemotherapy for colorectal cancer after combination regimens including 5-fluorouracil, irinotecan and oxaliplatin: a phase II studyGerardo Rosati, Antonio Rossi, Domenico Germano, et al.
The International Journal of Biochemistry & Cell Biology|June 10, 2015
A perspective on the current treatment strategies for locally advanced rectal cancerAntonio Avallone, Luigi Aloj, Giuseppe Aprile, et al.
Frontiers in Oncology|April 19, 2024
Clinical outcomes of intermittent panitumumab based-therapy for previously treated older patient with metastatic colorectal cancer: a case report and review of literatureGerardo Rosati, Luigi Annunziata, Enrico Scarano, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 4, 2005
Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survivalGerardo Rosati, Rosistella Chiacchio, Giorgio Reggiardo, et al.
Cancer Chemotherapy and Pharmacology|October 27, 2012
XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe studyGerardo Rosati, Antonio Avallone, Giuseppe Aprile, et al.
Tumori|May 6, 2003
Responsiveness of skin metastases to CMF in a patient with urothelial carcinoma of the bladder: a case reportGerardo Rosati, Antonio Rossi, Domenico Germano, et al.
Tumori|April 26, 2007
An adrenal gland nodule presenting as an early sign of metastatic spread from colorectal cancer: report of two casesGerardo Rosati, Giuseppe Tramutola, Nicola D'Alessandro, et al.
Medicine|June 21, 2018
Unexpected and durable response with regorafenib in a metastatic colorectal cancer patient without KDR mutation: A case reportGerardo Rosati, Nunzio Del Gaudio, Enrico Scarano, et al.
Oncology|August 28, 2004
A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancerGerardo Rosati, Aniello Tucci, Antonio Rinaldi, et al.
Pageof 9